NORDHEALTH AS A-AKSJER NORDH ADDITIONAL REGULATED INFORMATION REQUIRED TO BE DISCLOSED UNDER THE LAWS OF A MEMBER STATE

Nordhealth AS - Invitation to Q3 2026 presentation

04. November 2026 kl. 18:35

Nordhealth will report and present its Q3 2026 results on Tuesday the 10th of November 2026.

The results will be presented in a live presentation and subsequent Q&A session with CEO Charles MacBain and CFO Alexander Cram on the 10th of November at 16:00 CET.

Please use the following link to attend: https://us02web.zoom.us/j/83656301554

The presentation will be recorded and made available on www.nordhealth.com. The presentation material for Q3/2026 will be available on 10th November 2026 at 07:30 CET on www.newsweb.no (https://publish.ne.cision.com/l/hvqkaavqc/publish.ne.cision.co m/l/yjorrkoqe/publish.ne.cision.com/l/uxskchlrc/publish.ne.cision.com/l/afkpudtpe /www.newsweb.no) and on Nordhealth's IR website https://nordhealth.com/investor/news-and-documents/

For further information, please contact:

Charles MacBain, CEO charles.macbain@nordhealth.com

Alexander Cram, CFO alexander.cram@nordhealth.com

About Nordhealth

Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS company on a mission to redefine digital healthcare. We build software that empower veterinary and therapy professionals to provide the best possible care experiences to their patients. Our products serve more than 60,000 veterinary and therapy professionals across 13,000 clinics and hospitals located in over 30 countries.

Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the Nordic region and a growing presence internationally, with 400 employees working either remotely or from offices (collaboration hubs). Visit the company's website at nordhealth.com (http://www.nordhealth.com).